Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

David Dantzker

Pulmonary Disease New York, NY Medical Doctor

NPI 1871724575 CMS profile 957702

64 E 86Th St, Apt 1C, New York, NY 10028

Open in the dashboard

General payments

$41,383

213 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Dantzker of New York, NY is reported in the CMS Open Payments database as having received $41,383 across 213 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Pulmonary Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,337 37
2024 General $11,051 54
2023 General $13,108 70
2022 General $7,886 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Dantzker
  • Pulmonary Disease median
  • Middle half of Pulmonary Disease
  • National median

In program year 2025, general payments to David Dantzker were reported at $9,337. Among 8,914 Pulmonary Disease profiles paid that year, the median was $500 and the middle half received between $124 and $1,893.

Show as a table
Year David Dantzker Pulmonary Disease median Middle half National median
2019 $0 $377 $109–$1,340 $163
2020 $0 $230 $56–$907 $114
2021 $0 $269 $68–$1,072 $132
2022 $7,886 $390 $100–$1,457 $149
2023 $13,108 $419 $114–$1,659 $160
2024 $11,051 $476 $123–$1,818 $164
2025 $9,337 $500 $124–$1,893 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Surmodics, Inc. $41,383 213 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $33,077 112 payments
  2. Food and Beverage $8,306 101 payments
Products named General payments · program years 2022–2025
  1. SUNDANCE Drug Coated Balloon $25,654 126 payments
  2. SurVeil Drug-Coated Balloon $20,717 119 payments
  3. Sublime Microcatheter, 018, 200cm, Straight $20,389 91 payments
  4. Pounce Thrombectomy System $20,389 91 payments
  5. Pounce Thrombectomy $19,061 119 payments
  6. Sublime 014 Rx PTA Balloon Dilatation Catheter 014 Radial Catheter $18,806 71 payments
  7. TRANSCEND $14,406 41 payments
  8. Sublime Radial Access 018 RX PTA Dilatation Catheter $13,079 69 payments
  9. Sublime 014 Rx PTA Balloon Dilatation Catheter Peripheral angioplasty balloon catheter $13,079 69 payments
  10. SUNDANCE $9,469 34 payments
  11. Other $31,747 231 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

213 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pulmonary Disease in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record